Melanin-concentrating hormone receptor 1

MCHR1
Identifiers
Aliases	MCHR1, GPR24, MCH-1R, MCH1R, SLC-1, SLC1, melanin concentrating hormone receptor 1
External IDs	OMIM: 601751 MGI: 2180756 HomoloGene: 21097 GeneCards: MCHR1
Gene location (Human)
Chr.	Chromosome 22 (human)[1]
End	40,682,812 bp[1]
Gene location (Mouse)
Chr.	Chromosome 15 (mouse)[2]
End	81,123,165 bp[2]
RNA expression pattern
	Top expressed in
	endothelial cell; ; middle temporal gyrus; ; Brodmann area 23; ; prefrontal cortex; ; superior frontal gyrus; ; entorhinal cortex; ; postcentral gyrus; ; dorsolateral prefrontal cortex; ; cingulate gyrus; ; Brodmann area 46;
	Top expressed in
	Paneth cell; ; superior frontal gyrus; ; Region I of hippocampus proper; ; facial motor nucleus; ; substantia nigra; ; nucleus accumbens; ; soleus muscle; ; temporal muscle; ; anterior horn of spinal cord; ; olfactory tubercle;
	More reference expression data
	More reference expression data
Gene ontology
Molecular function	G protein-coupled receptor activity; signal transducer activity; melanin-concentrating hormone receptor activity; neuropeptide receptor activity; signaling receptor binding; protein C-terminus binding; hormone binding; neuropeptide binding; peptide binding;
Cellular component	integral component of membrane; plasma membrane; integral component of plasma membrane; membrane; ciliary membrane; non-motile cilium; cilium;
Biological process	G protein-coupled receptor signaling pathway; neuropeptide signaling pathway; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; generation of precursor metabolites and energy; feeding behavior; signal transduction; chemical synaptic transmission; cell surface receptor signaling pathway; positive regulation of cytosolic calcium ion concentration; positive regulation of calcium ion transport;
	Sources:Amigo / QuickGO
Orthologs
	2847
	207911
	ENSG00000128285
	ENSMUSG00000050164
	Q99705
	Q8JZL2
	NM_005297
	NM_145132
	NP_005288
	NP_660114
	Wikidata
View/Edit Human	View/Edit Mouse

Melanin-concentrating hormone receptor 1, also known as MCH₁, is one of the melanin-concentrating hormone receptors found in all mammals.[5]

The protein encoded by this gene, a member of the G protein-coupled receptor family 1, is an integral plasma membrane protein which binds melanin-concentrating hormone. The encoded protein can inhibit cAMP accumulation and stimulate intracellular calcium flux, and is probably involved in the neuronal regulation of food consumption. Although structurally similar to somatostatin receptors, this protein does not seem to bind somatostatin.[5]

Function

MCH₁ is thought to have a number of functions including in the regulation of appetite,[6][7] and in stress, anxiety and depression.[8][9][10][11][12][13]

Selective ligands

Agonists

Melanin concentrating hormone (MCH)
S-36057 - modified MCH 6-13 fragment substituted with 3-iodotyrosine at N-terminus via dioxyoctanoyl linker, used as ¹²⁵I radioligand for mapping MCH₁ in vivo.[14][15]
LK-184 (Procter & Gamble) is one pick[16]

Antagonists

References

GRCh38: Ensembl release 89: ENSG00000128285 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000050164 - Ensembl, May 2017
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: MCHR1 melanin-concentrating hormone receptor 1".
Luthin DR (Jul 2007). "Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists". Life Sciences. 81 (6): 423–40. doi:10.1016/j.lfs.2007.05.029. PMID 17655875.
Rivera G, Bocanegra-García V, Galiano S, Cirauqui N, Ceras J, Pérez S, Aldana I, Monge A (2008). "Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity". Current Medicinal Chemistry. 15 (10): 1025–43. doi:10.2174/092986708784049621. PMID 18393860.
Hervieu G (Aug 2003). "Melanin-concentrating hormone functions in the nervous system: food intake and stress". Expert Opinion on Therapeutic Targets. 7 (4): 495–511. doi:10.1517/14728222.7.4.495. PMID 12885269. S2CID 25629841.
Shimazaki T, Yoshimizu T, Chaki S (2006). "Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders". CNS Drugs. 20 (10): 801–11. doi:10.2165/00023210-200620100-00002. PMID 16999451. S2CID 32524553.
Hervieu GJ (Apr 2006). "Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances". Expert Opinion on Therapeutic Targets. 10 (2): 211–29. doi:10.1517/14728222.10.2.211. PMID 16548771. S2CID 37420990.
Smith DG, Davis RJ, Rorick-Kehn L, Morin M, Witkin JM, McKinzie DL, Nomikos GG, Gehlert DR (Jun 2006). "Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice". Neuropsychopharmacology. 31 (6): 1135–45. doi:10.1038/sj.npp.1300913. PMID 16205780.
Roy M, David N, Cueva M, Giorgetti M (Jan 2007). "A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression". Biological Psychiatry. 61 (2): 174–80. doi:10.1016/j.biopsych.2006.03.076. PMID 16934771. S2CID 39334337.
Saito Y, Nagasaki H (2008). "The melanin-concentrating hormone system and its physiological functions". Orphan G Protein-Coupled Receptors and Novel Neuropeptides. Results and Problems in Cell Differentiation. Vol. 46. pp. 159–79. doi:10.1007/400_2007_052. ISBN 978-3-540-78350-3. PMID 18227983.
Audinot V, Lahaye C, Suply T, Beauverger P, Rodriguez M, Galizzi JP, Fauchère JL, Boutin JA (Jun 2001). "[125I]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor". British Journal of Pharmacology. 133 (3): 371–8. doi:10.1038/sj.bjp.0704085. PMC 1572795. PMID 11375253.
Able SL, Ivarsson M, Fish RL, Clarke TL, McCourt C, Duckworth JM, Napier C, Katugampola SD (Aug 2009). "Localisation of melanin-concentrating hormone receptor 1 in rat brain and evidence that sleep parameters are not altered despite high central receptor occupancy". European Journal of Pharmacology. 616 (1–3): 101–6. doi:10.1016/j.ejphar.2009.06.009. PMID 19540226.
Koikov LN, Ebetino FH, Solinsky MG, Cross-Doersen D, Knittel JJ (2004). "Analogs of sub-nanomolar hMC1R agonist LK-184 [Ph(CH2)3CO-His-d-Phe-Arg-Trp-NH2]. An additional binding site within the human melanocortin receptor 1?". Bioorganic & Medicinal Chemistry Letters. 14 (15): 3997–4000. doi:10.1016/j.bmcl.2004.05.039. PMID 15225714.
Chaki S, Yamaguchi J, Yamada H, Thomsen W, Tran TA, Semple G, Sekiguchi Y (2005). "ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety". CNS Drug Reviews. 11 (4): 341–52. doi:10.1111/j.1527-3458.2005.tb00052.x. PMC 6741758. PMID 16614734.
Gehlert DR, Rasmussen K, Shaw J, Li X, Ardayfio P, Craft L, Coskun T, Zhang HY, Chen Y, Witkin JM (May 2009). "Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression". The Journal of Pharmacology and Experimental Therapeutics. 329 (2): 429–38. doi:10.1124/jpet.108.143362. PMID 19182070. S2CID 7770969.
Doggrell SA (Jun 2003). "Does the melanin-concentrating hormone antagonist SNAP-7941 deserve 3As?". Expert Opinion on Investigational Drugs. 12 (6): 1035–8. doi:10.1517/13543784.12.6.1035. PMID 12783607. S2CID 13219655.
David DJ, Klemenhagen KC, Holick KA, Saxe MD, Mendez I, Santarelli L, Craig DA, Zhong H, Swanson CJ, Hegde LG, Ping XI, Dong D, Marzabadi MR, Gerald CP, Hen R (Apr 2007). "Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis". The Journal of Pharmacology and Experimental Therapeutics. 321 (1): 237–48. doi:10.1124/jpet.106.109678. PMID 17237257. S2CID 717425.
Takekawa S, Asami A, Ishihara Y, Terauchi J, Kato K, Shimomura Y, Mori M, Murakoshi H, Kato K, Suzuki N, Nishimura O, Fujino M (Mar 2002). "T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist". European Journal of Pharmacology. 438 (3): 129–35. doi:10.1016/S0014-2999(02)01314-6. PMID 11909603.

External links

"Melanin-Concentrating Hormone Receptors: MCH₁". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000128285 - Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000050164 - Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[entrez-5] "Entrez Gene: MCHR1 melanin-concentrating hormone receptor 1".

[pmid17655875-6] Luthin DR (Jul 2007). "Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists". Life Sciences. 81 (6): 423–40. doi:10.1016/j.lfs.2007.05.029. PMID 17655875.

[pmid18393860-7] Rivera G, Bocanegra-García V, Galiano S, Cirauqui N, Ceras J, Pérez S, Aldana I, Monge A (2008). "Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity". Current Medicinal Chemistry. 15 (10): 1025–43. doi:10.2174/092986708784049621. PMID 18393860.

[pmid12885269-8] Hervieu G (Aug 2003). "Melanin-concentrating hormone functions in the nervous system: food intake and stress". Expert Opinion on Therapeutic Targets. 7 (4): 495–511. doi:10.1517/14728222.7.4.495. PMID 12885269. S2CID 25629841.

[pmid16999451-9] Shimazaki T, Yoshimizu T, Chaki S (2006). "Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders". CNS Drugs. 20 (10): 801–11. doi:10.2165/00023210-200620100-00002. PMID 16999451. S2CID 32524553.

[pmid16548771-10] Hervieu GJ (Apr 2006). "Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances". Expert Opinion on Therapeutic Targets. 10 (2): 211–29. doi:10.1517/14728222.10.2.211. PMID 16548771. S2CID 37420990.

[pmid16205780-11] Smith DG, Davis RJ, Rorick-Kehn L, Morin M, Witkin JM, McKinzie DL, Nomikos GG, Gehlert DR (Jun 2006). "Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice". Neuropsychopharmacology. 31 (6): 1135–45. doi:10.1038/sj.npp.1300913. PMID 16205780.

[pmid16934771-12] Roy M, David N, Cueva M, Giorgetti M (Jan 2007). "A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression". Biological Psychiatry. 61 (2): 174–80. doi:10.1016/j.biopsych.2006.03.076. PMID 16934771. S2CID 39334337.

[pmid18227983-13] Saito Y, Nagasaki H (2008). "The melanin-concentrating hormone system and its physiological functions". Orphan G Protein-Coupled Receptors and Novel Neuropeptides. Results and Problems in Cell Differentiation. Vol. 46. pp. 159–79. doi:10.1007/400_2007_052. ISBN 978-3-540-78350-3. PMID 18227983.

[pmid11375253-14] Audinot V, Lahaye C, Suply T, Beauverger P, Rodriguez M, Galizzi JP, Fauchère JL, Boutin JA (Jun 2001). "[125I]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor". British Journal of Pharmacology. 133 (3): 371–8. doi:10.1038/sj.bjp.0704085. PMC 1572795. PMID 11375253.

[pmid19540226-15] Able SL, Ivarsson M, Fish RL, Clarke TL, McCourt C, Duckworth JM, Napier C, Katugampola SD (Aug 2009). "Localisation of melanin-concentrating hormone receptor 1 in rat brain and evidence that sleep parameters are not altered despite high central receptor occupancy". European Journal of Pharmacology. 616 (1–3): 101–6. doi:10.1016/j.ejphar.2009.06.009. PMID 19540226.

[16] Koikov LN, Ebetino FH, Solinsky MG, Cross-Doersen D, Knittel JJ (2004). "Analogs of sub-nanomolar hMC1R agonist LK-184 [Ph(CH2)3CO-His-d-Phe-Arg-Trp-NH2]. An additional binding site within the human melanocortin receptor 1?". Bioorganic & Medicinal Chemistry Letters. 14 (15): 3997–4000. doi:10.1016/j.bmcl.2004.05.039. PMID 15225714.

[pmid16614734-17] Chaki S, Yamaguchi J, Yamada H, Thomsen W, Tran TA, Semple G, Sekiguchi Y (2005). "ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety". CNS Drug Reviews. 11 (4): 341–52. doi:10.1111/j.1527-3458.2005.tb00052.x. PMC 6741758. PMID 16614734.

[pmid19182070-18] Gehlert DR, Rasmussen K, Shaw J, Li X, Ardayfio P, Craft L, Coskun T, Zhang HY, Chen Y, Witkin JM (May 2009). "Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression". The Journal of Pharmacology and Experimental Therapeutics. 329 (2): 429–38. doi:10.1124/jpet.108.143362. PMID 19182070. S2CID 7770969.

[pmid12783607-19] Doggrell SA (Jun 2003). "Does the melanin-concentrating hormone antagonist SNAP-7941 deserve 3As?". Expert Opinion on Investigational Drugs. 12 (6): 1035–8. doi:10.1517/13543784.12.6.1035. PMID 12783607. S2CID 13219655.

[pmid17237257-20] David DJ, Klemenhagen KC, Holick KA, Saxe MD, Mendez I, Santarelli L, Craig DA, Zhong H, Swanson CJ, Hegde LG, Ping XI, Dong D, Marzabadi MR, Gerald CP, Hen R (Apr 2007). "Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis". The Journal of Pharmacology and Experimental Therapeutics. 321 (1): 237–48. doi:10.1124/jpet.106.109678. PMID 17237257. S2CID 717425.

[pmid11909603-21] Takekawa S, Asami A, Ishihara Y, Terauchi J, Kato K, Shimomura Y, Mori M, Murakoshi H, Kato K, Suzuki N, Nishimura O, Fujino M (Mar 2002). "T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist". European Journal of Pharmacology. 438 (3): 129–35. doi:10.1016/S0014-2999(02)01314-6. PMID 11909603.